# A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis

> **NCT00257855** · PHASE2 · COMPLETED · sponsor: **University College London Hospitals** · enrollment: 120 (—)

## Conditions studied

- Secondary Progressive Multiple Sclerosis

## Interventions

- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT00257855
- **Lead sponsor:** University College London Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2009-01
- **Final completion:** 2009-02
- **Target enrollment:** 120 (—)
- **Last updated:** 2010-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257855, "A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00257855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*